Skip to main content

Moderna COVID-19 vaccine may pose higher heart inflammation risk: CDC

Share

Moderna's COVID-19 vaccine may pose a higher risk of heart inflammation in some age groups than Pfizer-BioNTech's shot, the U.S. Centers for Disease Control and Prevention said on Tuesday, citing recent data.

The agency, however, said the findings on myocarditis and pericarditis, types of heart inflammation linked to both the mRNA shots, were not consistent across all of the U.S. vaccine safety monitoring systems.

The CDC's analysis comes as the U.S. Food and Drug Administration's advisers meet on Tuesday to discuss the authorization of Moderna's vaccine for children and teens aged 6-17.

Based on data from the Vaccine Safety Datalink (VSD) system, the incidence of heart inflammation was 97.3 cases per million doses for males aged 18-39 following a second dose of Moderna's shot, versus 81.7 cases per million Pfizer vaccine doses.

Available information suggests that most people with myocarditis after mRNA COVID-19 vaccination recover over time, the CDC said.

Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty and Anil D'Silva

CTVNews.ca Top Stories

BUDGET 2024

BUDGET 2024 Feds cutting 5,000 public service jobs, looking to turn underused buildings into housing

Five thousand public service jobs will be cut over the next four years, while underused federal office buildings, Canada Post properties and the National Defence Medical Centre in Ottawa could be turned into new housing units, as the federal government looks to find billions of dollars in savings and boost the country's housing portfolio.

'I Google': Why phonebooks are becoming obsolete

Phonebooks have been in circulation since the 19th century. These days, in this high-tech digital world, if someone needs a phone number, 'I Google,' said Bridgewater, N.S., resident Wayne Desouza.

Local Spotlight

Stay Connected